Us2.ca
Overview
Us2.ai is an FDA-cleared and CE-marked artificial intelligence platform that fully automates echocardiography analysis, transforming cardiac diagnostics. It connects to ultrasound devices and PACS, processing echocardiograms in real time to deliver standardized, clinician-ready reports in seconds, not minutes. Unlike semi-automated tools, Us2.ai provides a complete structured report, including measurements, disease detection, and findings, often with zero clicks.
The platform is designed to improve workflow efficiency, reduce reporting time by up to 70%, and enhance diagnostic accuracy, addressing challenges like sonographer shortages and increasing clinical demands. Us2.ai’s AI-powered software automatically analyzes all heart chambers using both 2D and Doppler views, providing automated estimations of various cardiac structural and functional parameters. It incorporates deep learning pattern recognition with guideline-based echocardiographic measurements for automated detection of conditions such as cardiac amyloidosis, heart failure (HFpEF/HFrEF), pulmonary hypertension, and aortic stenosis.
Us2.ai supports clinical decision-making by providing fully explainable AI outcomes with transparent visual overlays and editable annotations directly from reports. The system integrates seamlessly with existing echo devices, CVIS, EMR, and PACS, offering both cloud and on-premise deployment options to ensure data security and compatibility with various infrastructures. Its technology is validated by peer-reviewed evidence and is used globally to democratize expert-level cardiac diagnostics, making high-quality, consistent, and inexpensive echo analysis accessible to healthcare providers worldwide.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Fully automated echocardiography analysis (zero clicks)
- Real-time processing and structured report generation
- AI-powered disease detection (e.g., Cardiac Amyloidosis, Heart Failure, Aortic Stenosis, Pulmonary Hypertension)
- Integration with ultrasound devices, PACS, CVIS, and EMR
- Guideline-based measurements and disease indication conclusions
- Explainable AI with editable annotations and visual overlays
- Comprehensive cardiac structural and functional parameters (2D, Doppler, M-mode, strain imaging)
- Cloud and on-premise deployment options
- Enterprise-grade security and compliance (ISO 27001:2022, MDSAP)
- Vendor-neutral platform
Use Cases
- Accelerating cardiac diagnosis and reporting
- Improving workflow efficiency in echo labs
- Standardized echo reporting for clinical trials and research
- Population-level disease screening and retrospective analysis (EHR mining)
- Supporting remote cardiovascular care and resource-limited settings
- Enhancing clinical decision-making for cardiologists and sonographers
What Physicians Need to Know
Us2.ai can significantly reduce the manual workload for sonographers, allowing them to focus on image quality rather than manual measurements. The AI provides consistent and reproducible measurements, which can help reduce variability between sonographers and improve diagnostic accuracy. The platform's ability to detect conditions like cardiac amyloidosis, heart failure, aortic stenosis, and pulmonary hypertension automatically can aid in earlier diagnosis and treatment. Physicians should remember that while AI provides valuable insights and pre-populated reports, the final clinical authority and sign-off remain with the physician. The system is designed to augment, not replace, medical judgment.
Us2.ai is designed for flexible integration into existing clinical workflows. It is vendor-neutral and can connect to ultrasound devices from manufacturers like GE, Philips, Siemens, and Canon, as well as handheld POCUS devices. Integration pathways include direct bundling with ultrasound systems, availability through AI marketplaces (e.g., Viz.ai, Aidoc), and seamless integration with PACS, CVIS, and EMR systems via DICOM routing, DICOM-SR, HL7, and PDF. Notable partnerships include Merge Cardio, Fujifilm, and Viz.ai, allowing for AI insights to appear natively within these platforms.
Details
| Category | Cardiology AI, Radiology & Imaging AI |
| Pricing | Unknown |
| Free Trial | Unknown |
| Deployment | Vendor-neutral across GE, Philips, Siemens, Canon and handheld POCUS. |
| Compliance | |
| BAA Available | Yes AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology, Radiology |
What the Web Says
Us2.ai is an AI-driven echocardiography analysis platform designed to automate the interpretation of echocardiograms, aiming to improve efficiency, consistency, and accessibility in cardiac care. Physicians and sonographers have reported positive experiences, noting improvements in measurement accuracy and workflow efficiency. The platform generates comprehensive, guideline-based reports with automated measurements and disease detection, reducing manual intervention.
Overall: PositiveStrengths
- Significant reduction in diagnosis and reporting time, saving an average of 10-12 minutes per study or up to 70% faster reporting.
- Enhances measurement accuracy and consistency, reducing variability between sonographers.
- Provides fully automated, comprehensive, and guideline-based reports with zero clicks.
- Vendor-neutral, integrating with various ultrasound machines and POCUS devices.
- Supports early detection of various heart conditions, including cardiac amyloidosis, heart failure, and pulmonary hypertension.
- Reduces workload for medical staff and can potentially lower treatment costs.
Limitations
- Some structural parameters show moderate agreement with expert review, and the AI may withhold classifications that experts can reach.
- The current algorithm does not report on all conditions, such as pericardial effusion, aortic regurgitation, and mitral stenosis.
- Its validated scope covers only part of what emergency department echocardiography must address, and reports may not mark unassessed parameters.
- Human expert review of AI reports is still required.
- One Reddit discussion raises general concerns about the accuracy, training, and trust in AI tools in echocardiography.
- There are questions about the safety and accuracy of using Us2.ai by untrained physicians, suggesting that some level of formal echocardiography training might still be necessary.
Based on reviews from: g2.com, reddit.com, toolify.ai, nih.gov, us2.ai, slashdot.org, testdynamics.net, youtube.com, theimagingwire.com, healthairegister.com
Last updated: 2026-10-29
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Us2.ca
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for Us2.ca.
AI Echo with Clinical & Lab Data for Cardiac Amyloidosis | Dr. Jeremy Slivnick
US2 ai
救難飛行艇US-2が3mの波で壊れない理由
機械解剖図鑑
탑백귀 모두를 울린 진심🥹 김수아의 위로가 담긴 '사랑이란' | 우리들의 발라드 2 | SBS
SBS
THE PROMISE THAT BROKE US 2 - CLINTON JOSHUA , CHISOM AGOAWUIKE | LATEST 2026 NIGERIAN MOVIE
VSTA Ent TV
Ce fan avait créé un multijoueur pour The Last of Us 2… 😭
nakai.
Acoustics, talk verse. Performed by uS2, writer D.A.Steele. #new original music #2026 #band #duo
Steele songs
Frequently Asked Questions
Compare Us2.ca
VS
VS
VS
VS
